Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors

US Patent 7572794 · Granted Aug 11, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystal forms of the monosodium salt of foramsulfuron2023
Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors2022
Crystal forms of the monosodium salt of foramsulfuron2019
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group2018
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine gr2018
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group2017
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group2017
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group2017
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group2017
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine gr2017
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group2017
Imidazopyridazines as Akt kinase inhibitors2017